Is this you? Create Your Porfile
Avatar

Sachiko Kobayashi

SANTEN PHARMACEUTICAL CO., LTD.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Sachiko Kobayashi is active.

Explore More

Publication

Featured researches published by Sachiko Kobayashi.

Archive | 2006

Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity

Mamoru Matsuda; Toshiyuki Mori; Kenji Kawashima; Masato Nagatsuka; Sachiko Kobayashi; Minoru Yamamoto; Masatomo Kato; Miwa Takai; Tomoko Oda

Archive | 2007

Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents

Mamoru Matsuda; Masato Nagatsuka; Toshiyuki Mori; Sachiko Kobayashi; Masatomo Kato; Miwa Takai

Archive | 2007

Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents

Mamoru Matsuda; Masato Nagatsuka; Toshiyuki Mori; Sachiko Kobayashi; Masatomo Kato; Miwa Takai

Archive | 2007

Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity

Mamoru Matsuda; Toshiyuki Mori; Kenji Kawashima; Minoru Yamamoto; Masatomo Kato; Miwa Takai; Masato Nagatsuka; Sachiko Kobayashi

Archive | 2008

Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity

Mamoru Matsuda; Toshiyuki Mori; Masaaki Nagatsuka; Sachiko Kobayashi; Masatomo Kato; Miwa Takai

Archive | 2013

1,2,3,4-TETRAHYDROQUINOXALINE COMPOUNDS HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY

Mamoru Matsuda; Toshiyuki Mori; Kenji Kawashima; Minoru Yamamoto; Masatomo Kato; Miwa Takai; Masato Nagatsuka; Sachiko Kobayashi

Archive | 2008

1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity

Mamoru Matsuda; Toshiyuki Mori; Masato Nagatsuka; Sachiko Kobayashi; Masatomo Kato; Miwa Takai

Archive | 2007

1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity

Mamoru Matsuda; Toshiyuki Mori; Kenji Kawashima; Minoru Yamamoto; Masatomo Kato; Miwa Takai; Masato Nagatsuka; Sachiko Kobayashi

Archive | 2012

METHODS FOR PREVENTING OR TREATING METABOLIC DISEASES, INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, ALLERGIC DISEASES, CENTRAL NERVOUS SYSTEM DISEASES, CARDIOVASCULAR DISEASES, HOMEOSTASIS-RELATED DISEASES OR GLAUCOMA

Mamoru Matsuda; Toshiyuki Mori; Masato Nagatsuka; Sachiko Kobayashi; Masatomo Kato; Miwa Takai

Archive | 2012

Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound

Mamoru Matsuda; Toshiyuki Mori; Masato Nagatsuka; Sachiko Kobayashi; Masatomo Kato; Miwa Takai

Explore More

Collaboration

Dive into the Sachiko Kobayashi's collaboration.

Top Co-Authors
Avatar

Mamoru Matsuda

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Masatomo Kato

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Miwa Takai

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Toshiyuki Mori

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Masato Nagatsuka

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Kenji Kawashima

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Minoru Yamamoto

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Tomoko Oda

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors
Avatar

Masaaki Nagatsuka

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge